168 related articles for article (PubMed ID: 28027119)
21. Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor).
Ferenc T; Wroński JW; Kopczyński J; Kulig A; Sidor M; Stalińska L; Dziki A; Sygut J
Pathol Res Pract; 2009; 205(5):311-24. PubMed ID: 19124205
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic Utility of LEF1 Immunostain in Cytology Specimens of Solid Pseudopapillary Neoplasm of Pancreas].
Farzaneh T; Nowroozizadeh B; Han M; Lee W
Acta Cytol; 2021; 65(3):250-256. PubMed ID: 33887729
[TBL] [Abstract][Full Text] [Related]
23. An unusual finding in a desmoid-type fibromatosis of the pancreas: a case report and review of the literature.
Torres JC; Xin C
J Med Case Rep; 2018 May; 12(1):123. PubMed ID: 29751773
[TBL] [Abstract][Full Text] [Related]
24. [Clinicopathologic and genetic studies of desmoid-type fibromatosis].
Yang JL; Wang J; Zhou XY; Li XQ; Hou YY; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):145-50. PubMed ID: 16630502
[TBL] [Abstract][Full Text] [Related]
25. Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study.
Koike H; Nishida Y; Kohno K; Shimoyama Y; Motoi T; Hamada S; Kawai A; Ogose A; Ozaki T; Kunisada T; Matsumoto Y; Matsunobu T; Ae K; Gokita T; Sakai T; Shimizu K; Ishiguro N
Hum Pathol; 2019 Feb; 84():155-163. PubMed ID: 30292627
[TBL] [Abstract][Full Text] [Related]
26. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.
Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC
Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042
[TBL] [Abstract][Full Text] [Related]
27. 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression.
Shang D; Liu Y; Xu X; Han T; Tian Y
Cancer Lett; 2011 Dec; 311(2):230-6. PubMed ID: 21880414
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical Expression of Lymphoid Enhancer-binding Factor 1 in Low-grade Endometrial Stromal Tumors.
Niu S; Lu H; Li W; Hou Y
Int J Gynecol Pathol; 2023 Nov; ():. PubMed ID: 38085960
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic desmoid-type fibromatosis with beta-catenin gene mutation-Report of a case and review of the literature.
Tsukamoto Y; Imakita M; Nishitani A; Ito T; Izukura M; Hirota S
Pathol Res Pract; 2016 May; 212(5):484-9. PubMed ID: 26907785
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.
Singhi AD; Lilo M; Hruban RH; Cressman KL; Fuhrer K; Seethala RR
Mod Pathol; 2014 Oct; 27(10):1355-63. PubMed ID: 24658583
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature.
Carlson JW; Fletcher CD
Histopathology; 2007 Oct; 51(4):509-14. PubMed ID: 17711447
[TBL] [Abstract][Full Text] [Related]
32. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
[TBL] [Abstract][Full Text] [Related]
33. β-catenin (CTNNB1) mutation and LEF1 expression in sinonasal glomangiopericytoma (sinonasal-type hemangiopericytoma).
Suzuki Y; Ichihara S; Kawasaki T; Yanai H; Kitagawa S; Shimoyama Y; Nakamura S; Nakaguro M
Virchows Arch; 2018 Aug; 473(2):235-239. PubMed ID: 29736797
[TBL] [Abstract][Full Text] [Related]
34. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
35. Increased Expression of LEF1 and β-Catenin in Invasive Micropapillary Carcinoma of the Breast is Associated With Lymphovascular Invasion and Lymph Node Metastasis.
Dolezal D; Zhang X; Harigopal M
Appl Immunohistochem Mol Morphol; 2022 Sep; 30(8):557-565. PubMed ID: 35960138
[TBL] [Abstract][Full Text] [Related]
36. Molecular Pathogenesis of Sporadic Desmoid Tumours and Its Implications for Novel Therapies: A Systematised Narrative Review.
McLean TD; Duchi S; Di Bella C
Target Oncol; 2022 May; 17(3):223-252. PubMed ID: 35446005
[TBL] [Abstract][Full Text] [Related]
37. Aberrant beta-catenin and LEF1 expression may predict the clinical outcome for patients with oropharyngeal cancer.
Papagerakis P; Pannone G; Shabana AH; Depondt J; Santoro A; Ghirtis K; Berdal A; Papagerakis S
Int J Immunopathol Pharmacol; 2012; 25(1):135-46. PubMed ID: 22507326
[TBL] [Abstract][Full Text] [Related]
38. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
[TBL] [Abstract][Full Text] [Related]
39. Nuclear GSK-3β segregation in desmoid-type fibromatosis.
Meneghello C; Ousghir B; Rastrelli M; Anesi L; Sommariva A; Montesco MC; Rossi CR; Hladnik U; Segat D
Histopathology; 2013 Jun; 62(7):1098-108. PubMed ID: 23614534
[TBL] [Abstract][Full Text] [Related]
40. Fibromatosis - immunohistochemical evaluation, differential diagnosis from gastrointestinal tumors, and other mesenchymal tumours.
Lacka DE; Nasierowska-Guttmejer A
Prz Gastroenterol; 2019; 14(1):79-85. PubMed ID: 30944681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
